The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Central South University · University of Pittsburgh · +16 more institutions
Abstract
Ferroptosis is a form of regulated cell death that may facilitate the selective elimination of tumor cells. The tumor suppressor p53 (TP53) has been demonstrated to promote ferroptosis via a transcription-dependent mechanism. Here, we show that TP53 limits erastin-induced ferroptosis by blocking dipeptidyl-peptidase-4 (DPP4) activity in a transcription-independent manner. Loss of TP53 prevents nuclear accumulation of DPP4 and thus facilitates plasma-membrane-associated DPP4-dependent lipid peroxidation, which finally results in ferroptosis. These findings reveal a direct molecular link between TP53 and DPP4 in the control of lipid metabolism and may provide a precision medicine strategy for the treatment of…
Citation impact
- FWCI
- 29.74
- Percentile
- 100%
- References
- 61
Authors
15- YXYangchun Xie
Central South University, University of Pittsburgh, Third Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Guangdong Province, Xiangya Hospital Central South University, Guangzhou Medical University
- SZShan Zhu
Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University
- XSXinxin Song
University of Pittsburgh
- XSXiaofang Sun
Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University
- YFYong Fan
Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University
Topics & keywords
- Suppressor
- Transcription factor
- Cell biology
- Chemistry
- Transcription (linguistics)
- Cancer research
- Endogeny
- Programmed cell death
- Good health and well-being
Funding
- ACAmerican Cancer SocietyAward: RSG-16-014-01-CDD
- APAssociation pour la Recherche sur le Cancer
- JHJohns Hopkins University
- ECEuropean Commission
- FLFondation Leducq
- NNNational Natural Science Foundation of ChinaAwards: 8177100253, 31671435, 81400132
- FPFondation pour la Recherche Médicale
- NSNatural Science Foundation of Guangdong ProvinceAward: 2016A030308011
- LCLigue Contre le Cancer
- IUInstitut Universitaire de France
- INInstitut National Du Cancer
- CICancéropôle Ile de France
- GSGuangdong Science and Technology DepartmentAward: 2016B030229008
- NINational Institutes of HealthAwards: R01GM115366, R01CA181450, R01CA160417
- CICancer Institute, University of PittsburghAward: P30CA047904
- HEH2020 European Research Council